4//SEC Filing
Nash Huw M. 4
Accession 0001209191-23-019656
CIK 0001623526other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:33 PM ET
Size
8.1 KB
Accession
0001209191-23-019656
Insider Transaction Report
Form 4
Nash Huw M.
COO & CBO
Transactions
- Award
Employee Stock Option (Right to Buy)
2023-03-15+78,600→ 78,600 totalExercise: $9.15Exp: 2033-03-14→ Common Stock (78,600 underlying) - Award
Restricted Stock Unit (RSU)
2023-03-15+52,400→ 52,400 totalExp: 2027-03-15→ Common Stock (52,400 underlying)
Footnotes (3)
- [F1]The option vests as to 1/48th of the total shares on April 15, 2023 and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 1/4th of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the issuer through each vesting date.
Documents
Issuer
Stoke Therapeutics, Inc.
CIK 0001623526
Entity typeother
Related Parties
1- filerCIK 0001780085
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:33 PM ET
- Size
- 8.1 KB